Extreme Hyperferritinemia: Causes and Prognosis.

ferritin hemophagocytic lymphohistiocytosis hyperferritinemia hyperferritinemic syndrome septic shock

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
16 Sep 2022
Historique:
received: 28 08 2022
revised: 11 09 2022
accepted: 14 09 2022
entrez: 23 9 2022
pubmed: 24 9 2022
medline: 24 9 2022
Statut: epublish

Résumé

The significance of extreme hyperferritinemia and its association with certain diagnoses and prognoses are not well characterized. We performed a retrospective analysis of adult patients with at least one total serum ferritin (TSF) measurement ≥ 5000 µg/L over 2 years, in three university hospitals. Conditions associated with hyperferritinemia were collected, and patients were classified into 10 etiological groups. Intensive care unit (ICU) transfer and mortality rates were recorded. A total of 495 patients were identified, of which 56% had a TSF level between 5000 and 10,000 µg/L. There were multiple underlying causes in 81% of the patients. The most common causes were infections (38%), hemophagocytic lymphohistiocytosis (HLH, 18%), and acute hepatitis (14%). For TSF levels > 10,000 µg/L, there were no solid cancer or hematological malignancy without another cause of hyperferritinemia. Isolated iron-overload syndromes never exceeded TSF levels > 15,000 µg/L. Extreme hyperferritinemia (TSF levels > 25,000 µg/L) was associated with only four causes: HLH, infections, acute hepatitis and cytokine release syndromes. A total of 32% of patients were transferred to an ICU, and 28% died. Both ICU transfer rate and mortality were statistically associated with ferritin levels. An optimized threshold of 13,405 μg/L was the best predictor for the diagnosis of HLH, with a sensitivity of 76.4% and a specificity of 79.3%. Hyperferritinemia reflects a variety of conditions, but only four causes are associated with extreme hyperferritinemia, in which HLH and acute hepatitis are the most common. Extreme hyperferritinemia has a poor prognosis with increased mortality.

Identifiants

pubmed: 36143085
pii: jcm11185438
doi: 10.3390/jcm11185438
pmc: PMC9505036
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Clin Rheumatol. 2013 Sep;19(6):324-8
pubmed: 23965472
Int J Hematol. 2016 Jun;103(6):686-92
pubmed: 27084250
Blood. 2015 Mar 5;125(10):1548-52
pubmed: 25573993
Pediatr Crit Care Med. 2017 Feb;18(2):143-150
pubmed: 27941423
Semin Diagn Pathol. 2019 Nov;36(6):404-414
pubmed: 31405537
Clin Microbiol Infect. 2020 Nov;26(11):1557.e9-1557.e15
pubmed: 32120038
BMC Med. 2013 Aug 22;11:185
pubmed: 23968282
Hematology. 2018 Dec;23(10):817-822
pubmed: 29914346
Eur J Haematol. 2020 Apr;104(4):344-351
pubmed: 31991015
J Clin Med. 2021 May 07;10(9):
pubmed: 34067164
Arthritis Rheumatol. 2014 Sep;66(9):2613-20
pubmed: 24782338
J Immunol. 2021 Apr 1;206(7):1561-1568
pubmed: 33692146
Int J Hematol. 2015 Aug;102(2):195-9
pubmed: 25997871
J Rheumatol. 2017 Jul;44(7):996-1003
pubmed: 28412707
J Dtsch Dermatol Ges. 2017 Nov;15(11):1081-1088
pubmed: 28981179
Int J Clin Pract. 2018 May 31;:e13215
pubmed: 29855115
Blood. 2017 Mar 23;129(12):1646-1657
pubmed: 28087540
World J Gastroenterol. 2006 Sep 28;12(36):5866-9
pubmed: 17007054
Pediatr Blood Cancer. 2007 Feb;48(2):124-31
pubmed: 16937360
Intensive Care Med. 1989;15(3):171-8
pubmed: 2738221
Clin Chem. 2014 Nov;60(11):1419-28
pubmed: 25156997
Hemasphere. 2019 Mar 29;3(2):e191
pubmed: 31723828
Ann Rheum Dis. 2012 Apr;71(4):484-92
pubmed: 22388996
Br J Haematol. 2018 May;181(3):331-340
pubmed: 29672840
Reumatismo. 2020 Jan 28;71(4):199-202
pubmed: 31995958
Ann Rheum Dis. 2016 Mar;75(3):481-9
pubmed: 26865703
Arthritis Rheumatol. 2019 Sep;71(9):1400-1412
pubmed: 31385462
Intern Med J. 2015 Aug;45(8):828-33
pubmed: 25851400
Lupus. 2013 Nov;22(13):1327-35
pubmed: 24036580
J Clin Pathol. 2013 May;66(5):438-40
pubmed: 23372179
Crit Care Med. 2020 Apr;48(4):459-465
pubmed: 32205591
Br J Dermatol. 2007 Mar;156(3):609-11
pubmed: 17300272
Blood. 2019 Jun 6;133(23):2465-2477
pubmed: 30992265
J Autoimmun. 2009 May-Jun;32(3-4):240-5
pubmed: 19324520
Medicine (Baltimore). 2002 May;81(3):194-200
pubmed: 11997716
Presse Med. 2017 Dec;46(12 Pt 2):e329-e338
pubmed: 29150231
Pediatr Crit Care Med. 2011 Nov;12(6):e233-6
pubmed: 21263363
Am J Clin Pathol. 2016 May;145(5):646-50
pubmed: 27247369
Ann Hematol. 2017 Oct;96(10):1667-1672
pubmed: 28762079
Crit Care Med. 2016 Nov;44(11):e1045-e1053
pubmed: 27441901

Auteurs

Maxime Fauter (M)

Department of Internal Medicine, University Hospital Croix-Rousse, Lyon 1 University, 69004 Lyon, France.
CIRI, Centre International de Recherche en Infectiologie, Inserm U1111, Lyon 1 University, CNRS, UMR5308, ENS de Lyon, 69007 Lyon, France.

Sabine Mainbourg (S)

Department of Internal Medicine and Vascular Pathology, University Hospital Lyon Sud, Lyon 1 University, 69000 Lyon, France.
Laboratoire de Biométrie et Biologie Evolutive, Université de Lyon, Université Lyon 1, CNRS, UMR 5558, 69622 Villeurbanne, France.
LIFE, Lyon Immunology Federation, 69000 Lyon, France.

Thomas El Jammal (T)

Department of Internal Medicine, University Hospital Croix-Rousse, Lyon 1 University, 69004 Lyon, France.

Arthur Guerber (A)

Department of Internal Medicine, University Hospital Croix-Rousse, Lyon 1 University, 69004 Lyon, France.

Sabine Zaepfel (S)

Department of Biochemistry and Molecular Biology, University Hospital Croix-Rousse, Hospices Civils de Lyon, 69004 Lyon, France.

Thomas Henry (T)

CIRI, Centre International de Recherche en Infectiologie, Inserm U1111, Lyon 1 University, CNRS, UMR5308, ENS de Lyon, 69007 Lyon, France.

Mathieu Gerfaud-Valentin (M)

Department of Internal Medicine, University Hospital Croix-Rousse, Lyon 1 University, 69004 Lyon, France.

Pascal Sève (P)

Department of Internal Medicine, University Hospital Croix-Rousse, Lyon 1 University, 69004 Lyon, France.
Research on Healthcare Performance (RESHAPE), INSERM U1290, Lyon 1 University, 69373 Lyon, France.

Yvan Jamilloux (Y)

Department of Internal Medicine, University Hospital Croix-Rousse, Lyon 1 University, 69004 Lyon, France.
CIRI, Centre International de Recherche en Infectiologie, Inserm U1111, Lyon 1 University, CNRS, UMR5308, ENS de Lyon, 69007 Lyon, France.
LIFE, Lyon Immunology Federation, 69000 Lyon, France.

Classifications MeSH